Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug;105(8):e55-63.
doi: 10.2105/AJPH.2015.302664. Epub 2015 Jun 11.

National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment

Christopher M Jones  1 , Melinda Campopiano  1 , Grant Baldwin  1 , Elinore McCance-Katz  1
Affiliations

National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment

Christopher M Jones et al. Am J Public Health. 2015 Aug.

Abstract

Objectives: We estimated national and state trends in opioid agonist medication-assisted treatment (OA-MAT) need and capacity to identify gaps and inform policy decisions.

Methods: We generated national and state rates of past-year opioid abuse or dependence, maximum potential buprenorphine treatment capacity, number of patients receiving methadone from opioid treatment programs (OTPs), and the percentage of OTPs operating at 80% capacity or more using Substance Abuse and Mental Health Services Administration data.

Results: Nationally, in 2012, the rate of opioid abuse or dependence was 891.8 per 100 000 people aged 12 years or older compared with national rates of maximum potential buprenorphine treatment capacity and patients receiving methadone in OTPs of, respectively, 420.3 and 119.9. Among states and the District of Columbia, 96% had opioid abuse or dependence rates higher than their buprenorphine treatment capacity rates; 37% had a gap of at least 5 per 1000 people. Thirty-eight states (77.6%) reported at least 75% of their OTPs were operating at 80% capacity or more.

Conclusions: Significant gaps between treatment need and capacity exist at the state and national levels. Strategies to increase the number of OA-MAT providers are needed.

PubMed Disclaimer

Figures

FIGURE 1—
FIGURE 1—
Trends in past-year opioid abuse or dependence and opioid agonist medication-assisted treatment capacity: United States, 2003–2012. Note. OA-MAT = opioid agonist medication-assisted treatment; OTP = opioid treatment program.
FIGURE 2—
FIGURE 2—
Comparison of state rates of past-year opioid abuse or dependence and capacity for opioid agonist medication-assisted treatment: United States, 2012. Note. OA-MAT = opioid agonist medication-assisted treatment.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. US Department of Health and Human Services. Addressing prescription drug abuse in the United States: current activities and future opportunities. Available at: http://www.cdc.gov/homeandrecreationalsafety/overdose/hhs_rx_abuse.html. Accessed December 8, 2014.
    1. Johnson EM, Lanier WA, Merrill RM et al. Unintentional prescription opioid-related overdose deaths: description of decedents by next of kin or best contact, Utah, 2008–2009. J Gen Intern Med. 2013;28(4):522–529. - PMC - PubMed
    1. Hall AJ, Logan JE, Toblin RL et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300(22):2613–2620. - PubMed
    1. Bohnert AS, Valenstein M, Bair MJ et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305(13):1315–1321. - PubMed
    1. Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers—United States, 1999-2008. MMWR Morb Mortal Wkly Rep. 2011;60(43):1487–1492. - PubMed

MeSH terms

LinkOut - more resources